Quarterly report · Q1
3034.TEDINET S100OZXA
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥40.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥166.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥40.4bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥999m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥1.0bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥98.1bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥96.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥101.4bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥53.7bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥52.1bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥44.5bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥43.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥39.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.4bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥16.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥27.18 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥149.51 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.21 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 45.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥830m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥17m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥3.5bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥60m |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥349m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥40.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥40.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥77m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.5bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥80m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥80m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥770m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥15m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥3.2bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥3.2bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥64m |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥311m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥40.4bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥40.4bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥80m |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥2.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 350
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 中 淳 一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)杉 山 正 樹 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 40350000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 40550000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 166199000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1895000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 1760000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 10094000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1033000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1001000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 5489000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1027000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1002000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 5599000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 39562000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 44450000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 43881000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 101362000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 98114000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 95984000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 28.21 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 27.18 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 149.51 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.390 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.453 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.457 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38902785 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38902785 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 38902785 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 38902785 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 1200200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 37682300 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 376823 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 20285 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 38902785 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 376823 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 1200200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 1200200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0308 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |